Abel Hall LLC
ELV icon

Abel Hall LLC’s Elevance Health ELV Stock Holding History

Abel Hall LLC’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$262K Sell
674
-16
-2% -$6.38K 0.05% 510
2026
Q2 		$267K Buy
+690
New +$256K 0.05% 545
2026
Q1 		– Sell
-858
Closed -$301K – 866
2025
Q4 		$301K Buy
+858
New +$290K 0.07% 334

Other funds holding ELV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
Canoe Financial
Canoe Financial Calgary, Alberta, Canada $8.31B AUM 20.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Maj Invest Holding A/S
Maj Invest Holding A/S Copenhagen K, Denmark $2.26B AUM 22.4% 1-Year Est. Return
Marathon Asset Management (UK)
Marathon Asset Management (UK) London, United Kingdom $2.2B AUM 25.78% 1-Year Est. Return

Abel Hall LLC's ELV Position: Q3 2026 in Review

Abel Hall LLC reduced its Elevance Health (ELV) stake by 2.3% in Q3 2026, selling an estimated $6.38K and leaving 674 shares worth $262K. The position accounts for 0.05% of the portfolio, ranked #510.

Abel Hall LLC first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. The position peaked at $301K in Q4 2025. 540 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Abel Hall LLC held 674 shares of Elevance Health worth $262K as of Q3 2026.
  • Abel Hall LLC sold 16 Elevance Health shares in Q3 2026, an estimated $6.38K.
  • Elevance Health made up 0.05% of Abel Hall LLC's portfolio in Q3 2026, its #510 holding.
  • Abel Hall LLC first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's Elevance Health position peaked at $301K in Q4 2025.
  • 540 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.